Results 1 to 10 of about 2,473 (178)
Are topical keratolytic agents needed in the treatment of scalp psoriasis? [PDF]
Dermatology Online Journal, 2014 Topical corticosteroids are the primary treatment for scalp psoriasis. Keratolytic agents are promoted as adjunctive treatments. However, complex treatment regimens may result in poor adherence and outcomes.To evaluate the evidence for the need for use of topical keratolytic agents as opposed to topical corticosteroid monotherapy in the treatment of ...
Shokeen, Divya +3 more
openaire +5 more sources
Acta Medica Philippina, 2022 Pityriasis versicolor is a common fungal infection of the superficial skin layer caused by Malassezia furfur, a normal commensal in the skin. Keratolytic agents are popular, cheap, and readily available over-the-counter treatments for pityriasis versicolor.
Genuino, Rowena Natividad F. +4 more
openaire +4 more sources
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 [PDF]
Journal of Clinical Oncology, 2010 Purpose Hand-foot syndrome (HFS) is a dose-limiting toxicity of capecitabine for which no effective preventative treatment has been definitively demonstrated. This trial was conducted on the basis of preliminary data that a urea/lactic acid–based topical keratolytic agent (ULABTKA) may prevent HFS.
Sherry L, Wolf +10 more
openaire +4 more sources
Dermatological Effects of Different Keratolytic Agents on Acne Vulgaris
Journal of Clinical Trials, 2016 Acne vulgaris is a chronic inflammatory skin disease; it's one of the most common skin disorders and affects mainly adolescents and young adults. Keratolytic agents are widely used in treatment of acne from several years. In this study we aimed to evaluate and compare the cutaneous response of different keratolytic agents in management of acne vulgaris.
Essa Ajmi Alodeani
openaire +2 more sources
The treatment of plantar warts with a keratolytic agent and occlusion
Journal of Dermatological Treatment, 1991 In an open, multicentre study, patients with one to ten plantar warts on each foot were randomized prior to treatment for up to 17 weeks to receive either a keratolytic agent alone (Promicid gel) or the same agent covered by an occlusive plaster (Promicid occlusive dressing). A total of 170 patients completed the study.
N. K. Veien +6 more
openaire +2 more sources
Psoriasis part 2 – topical treatment, phototherapy and skin care [PDF]
Farmacja Polska, 2023 Psoriasis is a chronic inflammatory disease that requires the selection of appropriate pharmacotherapy and skin care. Topical treatment should be added in pharmacotherapy of every patient with psoriasis.
Ewa Zwierzyńska +2 more
doaj +1 more source
Response of papillon–Lefevre syndrome to acitretin
Indian Journal of Paediatric Dermatology, 2021 Papillon–Lefevre (PLS) is a rare autosomal recessive disorder of keratinization characterized by symmetric, trans-gradient type palmoplantar keratoderma (PPK), rapidly progressive periodontopathy, and precocious loss of dentition.
Priyanka Arun Kowe +3 more
doaj +1 more source
The use of urea for skin barrier correction [PDF]
Vestnik Dermatologii i Venerologii, 2022 The review summarizes information about the main causes and pathogenesis of xerosis cutis as one of the conditions indicating a violation of the epidermal barrier.
Vera I. Albanova +2 more
doaj +1 more source
Psoriasis in areas difficult to treat and biological therapy
Przegląd Dermatologiczny, 2021 Psoriasis often affects specific locations such as the nail apparatus, scalp, hands, feet, and genital areas. It usually coexists with severe plaque psoriasis. However in some cases only these areas may be affected, causing a significant deterioration of
Anna Lis-Święty, Aleksandra Frątczak
doaj +1 more source